Generic Tamiflu: Should developing countries ignore intellectual patents from developed nations? “First India said it would ignore Roche’s patents to make a generic form of Tamiflu and now Taiwan is saying the same thing. In both cases, they make the claim that saving the lives of their citizens is a lot more important than protecting the intellectual property of a foreign company.”
Generic Tamiflu: Should developing countries ignore intellectual patents from developed nations?
Kevin
Real physician voices, twice a week
Free, and one click to unsubscribe.
Keep reading
The Podcast
Listen on Apple · Spotify · YouTube
Latest episodes
Most popular

Why more medicine isn’t making us healthier

Amazon and Uber set the bar that primary care is judged against

Some relationships work like medicine. Others work like a diagnosis.

Food allergies are treated differently, airline by airline

Staying salaried may now be the riskier bet for doctors

Why patients stop trusting doctors who listened to them

Doctors’ kids miss them, and the family builds its own fixes


